EDITORIAL
Mens behaviour towards prostate cancer screening
1 Department of Urology, Barts & The London NHS Trust, London, UK
2 Department of Psychology, Panteion University of Social & Political Sciences, Athens, Greece
Correspondence to:
Dr A G Papatsoris, Department of Urology, Barts & The London NHS Trust, London, UK; agpapatsoris@yahoo.gr
Keywords: behaviour; prostate cancer; screening
| The first 150 words of the full text of this article appear below. |
Prostate cancer remains the most common non-cutaneous malignancy in the Western world and is the second leading cause of cancer death in males.1 The lifetime risk of developing and dying from prostate cancer rises substantially among men after the age of 50 years and a twofold greater risk exists among African–American men. Along with age and race, having a family history of prostate cancer is also a well-established risk factor. The incidence of prostate cancer has increased dramatically within the past decade, primarily due to the utilisation of serum prostate specific antigen (PSA) as a screening test that has resulted in earlier diagnosis.1 Prostate cancer screening means the examination of asymptomatic people in order to classify them according to whether they are likely or unlikely to have prostate cancer. Apart from PSA, screening includes digital rectal examination, trans-rectal ultrasound and biopsies on indication.
Several problems have beset the widespread acceptance
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
